This federal contract award, SPE2DB24D8003|SPE2DB25FJTKW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a firm fixed price of $2,734.80 and a completion date of December 10, 2024.
Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop Support Medical's ECAT Generation V Program. This contract allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award is not a set-aside contract.
Generated 3/16/25, 12:53 AM